China never isolated the COVID 19 virus--A New Conspiracy Theory

Not only did the Chinese ever isolate the COVID-19 virus, but the U.S. only made the virus from the DNA code sent to them.

Time has not weakened the conspiracy theorists.  Be wary of what you read.  

The nano-particles found in the mRNA vaccines when injected into humans can be programmed to perform activity on demand by an unknown 'government'.

La Quinta Columna recently published its findings and conclusions on the strange, self-assembling nanotech they discovered in the Pfizer mRNA vaccines via optical microscopy analysis. The objects found in the vaccines correspond with known items in the scientific records. The conclusions they’ve come to seem quite clear: the well-documented scientific goal to use nanotechnology in living human beings to form networks capable of controlling several nanomachines is currently being deployed in the COVID-19 vaccines, which amounts to the most intrusive assault against humanity in all of recorded history.

Graphene Oxide (GO2) Based Nano-Tech Powered by 5G Found in the Pfizer Vaccine

A little bit of knowledge can be a dangerous thing.  Persons disseminating 'false information' are not scientists, and have no proof of their suppositions.   A nanoparticle is a small particle that ranges between 1 to 100 nanometres in size. What are the effects of nanoparticles?

Graphene oxide is only one type of nanoparticle. 

Nanotechnology-Enhanced mRNA Vaccines | A Guide  (The Real Science)

La Quinta Columna recently published its findings and conclusions on the strange, self-assembling nanotech they discovered in the Pfizer mRNA vaccines via optical microscopy analysis. The objects found in the vaccines correspond with known items in the scientific records. The conclusions they’ve come to seem quite clear: the well-documented scientific goal to use nanotechnology in living human beings to form networks capable of controlling several nanomachines is currently being deployed in the COVID-19 vaccines, which amounts to the most intrusive assault against humanity in all of recorded history.

Over 1000 published studies provide evidence that the COVID-19 "vaccines" are DANGEROUS

https://www.thecompleteguidetohealth.com/over-1000-published-studies-provide-evidence-that-the-covid-19-vaccines-are-dangerous.html

• Fact - deaths due to the covid vaccines in the UK after 6 months are 407% higher than deaths due to all other vaccines combined in the past 11 years (https://theexpose.uk/2021/07/11/fact-deaths-due-to-the-covid-vaccines-in-the-uk-after-6-months-are-407-higher-than-deaths-due-to-all-other-vaccines-combined-in-the-past-11-years/comment-page-1/ )

• 7-year-old dies 11 days after Pfizer shot, VAERS report shows (https://childrenshealthdefense.org/defender/vaers-cdc-child-dies-pfizer-covid-vaccine/ )

• 34,337 deaths 3,120,439 injuries following covid shots in European database as UK public data show 35 deaths 213 hospitalizations among booster triple vaccinated. (https://vaccineimpact.com/2021/34337-deaths-3120439-injuries-following-covid-shots-in-european-database-as-uk-public-data-show-35-deaths-213-hospitalizations-among-booster-triple-vaccinated/ )

• 310 athlete cardiac arrests, serious issues, 177 dead, after covid shot (https://vaccineimpact.com/2021/310-athlete-cardiac-arrests-serious-issues-177-dead-after-covid-shot/ )

• A 5-year-old died 4 days after Pfizer shot, CDC VEARS data show (https://childrenshealthdefense.org/defender/vaers-cdc-adverse-events-deaths-5-year-old-died-pfizer-vaccine/ )

• 8-year-old girl has a stroke and brain hemorrhage 7 days after Pfizer covid-19 shot (https://vaccineimpact.com/2021/7-year-old-girl-has-stroke-and-brain-hemorrhage-7-days-after-pfizer-covid-19-shot/ )

• 120 teens hospitalized, 3 dead following Pfizer vaccine rollout for 15 to 17-year-olds in Vietnam (https://childrenshealthdefense.org/defender/teens-hospitalized-dead-pfizer-vaccine-vietnam/ )

• 2,620 dead babies in VAERS after covid shots… (https://vaccineimpact.com/2021/2620-dead-babies-in-vaers-after-covid-shots-more-fetal-deaths-in-11-months-than-past-30-years-following-all-vaccines-as-scotland-begins-investigation/ )

• 17-year-old develops multisystem inflammatory syndrome and myocarditis after Pfizer vaccine, report shows (https://childrenshealthdefense.org/defender/teen-multisystem-inflammatory-syndrome-myocarditis-pfizer-vaccine/ )

• 20-year-old loses her leg after second AstraZeneca jab in Surat Thani (https://www.nationthailand.com/in-focus/40007619 )

• 13-year-old boy loses eyesight 10 days after receiving the Pfizer covid-19 vaccine - mother seeks answers (https://thecovidworld.com/yassine-13-year-old-boy-loses-eyesight-10-days-after-receiving-the-pfizer-covid-19-vaccine-mother-seeks-answers/ )

• 14-year-old boy dies from massive brain bleed hours after receiving his second Pfizer covid-19 vaccine (https://thecovidworld.com/joshua-henry-14-year-old-boy-dies-from-massive-brain-bleed-hours-after-receiving-his-second-pfizer-covid-19-vaccine/ )

• A list of people who had their leg amputated after receiving the COVID-19 vaccine (https://thecovidworld.com/a-list-of-people-who-had-their-leg-amputated-after-receiving-covid-19-vaccine/ )

• Footballer, 23, dead from jab MSM cover it up (https://brandnewtube.com/watch/ireland-footballer-23-dead-from-jab-msm-cover-it-up-hugo-talks-lockdown_vV5TwFZ9jtnbYlV.html )

• Mother of a 17-year-old girl who lost the use of her limbs after having the Pfizer vaccine (https://www.bitchute.com/video/3fmoAq8IfkPX/ )

• Stevie Thrasher, 29 years old from Washington, injured after receiving the Pfizer vaccine (https://www.bitchute.com/video/g859h1JZXW9B/ )

• 13-year-old dies in sleep after receiving Pfizer covid vaccine; CDC investigating (https://www.newsweek.com/13-year-old-dies-sleep-after-receiving-pfizer-covid-vaccine-cdc-investigating-1606529 )

• Dad: My son's school made him get a covid vaccine, now he has a heart condition (https://childrenshealthdefense.org/defender/teen-heart-condition-pfizer-covid-vaccine-fabio-berlingieri-fox-friends/ )

• Laura Ingraham - interview with woman who suffered severe brain bleed after Moderna jab (https://www.bitchute.com/video/7QRLWTYsYxc2/ )

• Mother regrets putting 12-year-old daughter in Pfizer covid-19 vaccine trial (https://vaccineimpact.com/2021/former-nfl-player-collects-stories-of-lives-destroyed-by-the-covid-19-shots-mother-regrets-putting-12-year-old-daughter-in-pfizer-covid-19-vaccine-trial/ )

• 13-year-old Michigan boy dies three days after second dose of Pfizer vaccine, aunt says 'moral, ethical, health' questions need answers (https://childrenshealthdefense.org/defender/13-year-old-jacob-clynick-dies-pfizer-vaccine-myocarditis/ )

• Mum of three dies after receiving AstraZeneca coronavirus vaccine (https://www.walesonline.co.uk/news/uk-news/mum-three-dies-after-receiving-20914255 )

• Stephanie Wasil, 51, dies of cardiac arrest from the Moderna vaccine (https://www.bitchute.com/video/UceA3FGxtbJe/ )

• Family of Italian woman who died after Oxford AstraZeneca vaccine launches legal action (https://news.sky.com/story/covid-19-family-of-italian-woman-who-died-after-oxford-astrazeneca-vaccine-launches-legal-action-12278855 )

• Vietnamese woman dies after receiving AstraZeneca shot (https://www.chiangraitimes.com/thailand-national-news/news-asia/vietnamese-woman-dies-after-receiving-astrazeneca-vaccine-shot/ )

• Nurse develops Bell's Palsy after receiving COVID jab (video) https://brandnewtube.com/watch/nurse-with-bell-039-s-palsy-three-weeks-after-taking-nwo-pfizer-vaxx_2y4i9CfrSeCjH8Z.html

• A 28-year-old mother from Wisconsin is brain dead after the second dose of the COVID injection https://vaccineimpact.com/2021/28-year-old-wisconsin-healthcare-worker-has-aneurysm-brain-dead-five-days-after-second-experimental-pfizer-mrna-covid-injection/

• 58-year-old woman dies hours after getting first dose of Pfizer vaccine https://childrenshealthdefense.org/defender/woman-dies-hours-after-first-dose-pfizer-vaccine/

• 19-year-old hospitalized with heart inflammation after covid vaccine https://www.jpost.com/health-science/19-year-old-hospitalized-with-heart-inflammation-after-pfizer-vaccination-657428

• 39-year-old nurse aide dies within 48 hours of receiving the COVID jab https://www.lifesitenews.com/news/39-year-old-nurse-aide-dies-within-48-hours-of-receiving-mandated-covid-19-shot

• A 41-year-old Portuguese mother of two who worked in pediatrics died at a hospital in Porto just two days after being vaccinated against covid-19 https://www.dailymail.co.uk/news/article-9111311/Portuguese-health-worker-41-dies-two-days-getting-Pfizer-covid-vaccine.html

• 63-year-old man dies 2 days after covid-19 vaccination - "It's too early to tell whether the jab was related to his death" (https://news.rthk.hk/rthk/en/component/k2/1578391-20210302.htm )

• 56-year-old woman dies days after covid vaccine - "no link established so far" (https://indianexpress.com/article/cities/delhi/gurgaon-woman-dies-days-after-covid-shot-officials-say-no-link-established-so-far-7158220/ )

• 88-year-old dies hours after COVID vaccination in second such incident - "In both cases, medical professionals do not believe the deaths were connected to the vaccines" (https://www.jpost.com/israel-news/88-year-old-dies-hours-after-covid-vaccination-in-second-such-incident-653721 )

• Greek woman dies following AstraZeneca vaccine blood clot (https://greekreporter.com/2021/06/01/greek-woman-dies-following-astrazeneca-vaccine-blood-clot/ )

• Families of South Korea's COVID-19 vaccine victims mourn loved ones during mass memorial service (https://thecovidworld.com/families-of-south-koreas-covid-vaccine-victims-mourn-loved-ones-during-mass-memorial-service/ )

• Three footballers collapse in three days - (https://brandnewtube.com/watch/3-x-footballers-collapse-in-3-x-days-hugo-talks-lockdown_Eh8XQLJ79PQfFHe.html )

• Paul Dimattina: Australian football league legend rushed to hospital after severe reaction to Pfizer booster shot (https://thecovidworld.com/paul-dimattina-australian-football-league-legend-rushed-to-hospital-after-severe-reaction-to-pfizer-booster-shot/ )

• Sithipol Bovornkittipaisal: 26-year-old man dies 1 day after receiving Moderna covid-19 vaccine, investigation launched (https://thecovidworld.com/sithipol-bovornkittipaisal-26-year-old-man-dies-1-day-after-receiving-moderna-covid-19-vaccine-investigation-launched/ )

• As reports of injuries after covid vaccines near the 1 million mark, CDC, and FDA clear Pfizer, and Moderna boosters for all adults (https://childrenshealthdefense.org/defender/vaers-cdc-injuries-covid-vaccines-fda-pfizer-moderna-bosters/ )

• How many people in the key Pfizer COVID-19 vaccine trial died? More than Pfizer told you (https://childrenshealthdefense.org/defender/pfizer-six-month-data-update-covid-vaccine-clinical-trials/ )

• Pfizer secretly adds dangerous ingredient to injection for 5 to 11-year-olds as Taiwan stops Pfizer shots for 12 to 17-year-olds (https://vaccineimpact.com/2021/pfizer-secretly-adds-dangerous-ingredient-to-injections-for-5-to-11-year-olds-as-taiwan-stops-pfizer-shots-for-12-to-17-year-olds/ )

• Surge in reports of serious injuries as 5-year-olds start getting shots (https://childrenshealthdefense.org/defender/vaers-cdc-covid-vaccine-data-injuries-5-year-olds/ )

• German news agency compiles a list of 75 European athletes who have died "suddenly" in the past 5 months since being fully vaccinated. (https://threadreaderapp.com/thread/1455320859753787396.html )

• Woman left wheelchair-bound with neurological damage hours after Pfizer vaccine dose (https://theexpose.uk/2021/11/10/woman-left-wheelchair-bound-with-neurological-damage-hours-after-pfizer-vaccine-dose/ )

• US Children's Hospitals Now Overwhelmed with Infant Cardiac Patients (https://theexpose.uk/2021/11/10/us-childrens-hospitals-now-overwhelmed-with-infant-cardiac-patients/ )

• Worldwide surge of sports people suffering sudden health issues and death (https://www.notonthebeeb.co.uk/post/surge-of-sports-people-worldwide-suffering-unexpected-ill-health )

• mRna shots are 'gene therapy' marketed as 'vaccines' to gain public trust says Big Pharma (https://brandnewtube.com/watch/mrna-shots-are-gene-therapy-marketed-as-vaccines-to-gain-public-trust-says-big-pharma-hugo-tal_6pKHdRnHeSRAPZ8.html )

• Pfizer adds ingredient used to stabilize heart attack victims in vax for kids (https://presscalifornia.com/2021/10/28/pfizer-vax-kids/ )

• Astounding, heartbreaking adverse effects testimony about injections (https://brandnewtube.com/watch/astounding-heartbreaking-adverse-effects-testimony-about-injections_TYxzRPLrK1sId71.html )

• Funeral director: "I just see the dead babies in fridges" (https://odysee.com/@ResistanceGB:f/funeral-director-babies:c )

• This happened to her daughter Casey after one Pfizer jab (https://www.bitchute.com/video/dsIPC7tS6FWi/ )

• Two kids die from the same school within a week - (https://brandnewtube.com/watch/2-kids-die-from-same-school-within-a-week-hugo-talks-lockdown_JULsGAS31s8Edu7.html )

• Another teenage boy died after the "vaccine"…(https://www.bitchute.com/video/vGYRi6l22xyt/ )

• Covid world war press conference destroyed - "My friends are dead" (https://www.bitchute.com/video/BJArH6URr1bE/ )

• Jabbed-up rugby player has a massive heart attack and stroke in-game (https://brandnewtube.com/watch/jabbed-up-rugby-player-has-massive-heart-attack-and-stroke-in-game-hugo-talks-lockdown_W9wauZ9jhJGsNTJ.html )

• Scientist whose wife was injured by covid vaccine tells FDA: 'Please do not give this to kids (https://childrenshealthdefense.org/defender/brian-dressen-brianne-covid-pfizer-vaccine-risk-benefit-calculus-children/ )

• Murder charges filed after child vax death (https://brandnewtube.com/watch/murder-charges-filed-after-childs-vax-death_3pfFaMqFMeI9jcC.html )

• Covid vaccine injury - young healthy man & his partner - now suffer with myocarditis (https://www.bitchute.com/video/GME4eCNQ0Bji/ )

• Pharmacy manager of 10 years publicly quits her job…(https://www.bitchute.com/video/uGEUFY8Sbbg8/ )

• 1600 reports of hair loss following covid-19 shots (https://www.lifesitenews.com/news/1600-reports-of-hair-loss-following-covid-19-shots/ )

• Nurse can't walk or talk properly after covid booster (https://www.bitchute.com/video/UB3ccxs3wOTn/ )

• 40 Plus minutes of one major vaccine injury after another (https://www.bitchute.com/video/JyxhnTUdhf9S/ )

• Covid vaccine injury - woman speaks about her heart condition & warns others (https://www.bitchute.com/video/v2a9oSfxMKY0/ )

• Millions of vaccine-injured people across the world (https://www.bitchute.com/video/blwsbuapE8tH/ )

• Post covid-19 injections: the dead don't speak, but those with crippling injuries issue warnings (https://www.bitchute.com/video/0bRigrqy03ve/ )

• Shocking vaccine admissions from inside the WHO (https://www.bitchute.com/video/C8BCBUcu5gBl/ )

• Vaccine-induced ADE strikes the UK, MSM spins as 'super cold' (https://www.bitchute.com/video/AMwp1OIUR9T3/ )

• Covid-19 victims tell their stories (https://nomoresilence.world/ )

• Mandated medical worker has both legs, some fingers, and one hand amputated after COVID injection (https://www.bitchute.com/video/bgHgTDLWDdZ8/ )

• Daughter of man having arm amputated from clots after COVID vaccine speaks out (https://www.bitchute.com/video/32Ra8s1hzhIb/ )

• Horrific: baby paralyzed by covid vaccine (https://www.bitchute.com/video/XlsvWVqsgk7z/ )

• Covid vaccine multiple injuries - only 16-years-old and her life is completely destroyed (https://www.bitchute.com/video/YoH6nQvsb3LJ/ )

• Doctor's daughter jab reactions ignored (https://brandnewtube.com/watch/doctor-039-s-daughter-jab-reactions-ignored-ireland-hugo-talks-lockdown_GazPHRPlucwF4NX.html )

• Government HHS nurse Jodi O'Malley blows whistle on covid-19 vaccine injuries and deaths (https://www.bitchute.com/video/a7LOCJTLUqHI/ )

• Mother screams a warning in agony - her son died 2 days after the COVID jab (https://www.bitchute.com/video/booJm3DEWlMY/ )

• Mother in Canada left to die from vaccine injuries (https://www.bitchute.com/video/5UZI8B4hw70c/ )

• Horrific side effects of getting covid vaccine while pregnant (https://www.bitchute.com/video/yF2aEZnadgJM/ )

• Young woman loses little sister to vaccine - banned on social media (https://www.bitchute.com/video/HnGwBvrAsaAu/ )

• My best friend killed by the jab - another true horror story of the lethal injection (https://www.bitchute.com/video/zzLdieJuwu6x/ )

• Emotional plea "My son received the vaccine and died a few days later" (https://www.bitchute.com/video/sp9zuBvTcGHa/ )

• FBI agent took the COVID-19 vaccine and died within hours (https://www.bitchute.com/video/WdlEFVamUDS9/ )

• SARS-CoV-2 mRNA Vaccination-Associated Myocarditis in Children Ages 12-17: A Stratified National Database Analysis (https://www.medrxiv.org/content/10.1101/2021.08.30.21262866v1 )

• Polio virus to cover up kids jab adverse reactions (https://brandnewtube.com/watch/cdc-to-use-polio-virus-to-cover-up-kids-jab-adverse-reactions-hugo-talks-lockdown_pXcKgXAaC1hTTUK.html )

• Woman dies of rare brain disease within 3 months of second Pfizer shot, doctor says vaccine could be responsible (https://childrenshealthdefense.org/defender/cheryl-cohen-dies-rare-brain-disease-second-dose-pfizer-covid-shot/ )

• The vaccine murder of Roy Butler must not be covered up (https://www.bitchute.com/video/usgUB7zCAbFh/ )

• Navy doctor reveals more soldiers have died from the vaccine than died from COVID-19 (https://www.bitchute.com/video/yCVHTVWA1ADN/ )

• Australians speak out about deaths and adverse reactions soon after receiving covid vaccine (https://www.bitchute.com/video/cIgEyCrxKYgd/ )

• Enraged mother says the Pfizer vaccine killed her daughter in 5 hours (https://www.bitchute.com/video/5VeKXgIJw757/ )

• "Nothing but problems": double vaxxed man warns unvaxxed - 'Stand your ground. It's all a big lie (https://www.bitchute.com/video/FcjQX2RKxPbc/ )

• Exclusive interview: mum whose 14-year-old son developed myocarditis after Pfizer vaccine no longer trusts CDC, public health officials (https://childrenshealthdefense.org/defender/emily-jo-14-year-old-son-aiden-myocarditis-pfizer-vaccine/ )

• Covid vaccine deaths "In 6 months. Thousands dead. Millions injured" (https://covidvaccinedeaths.org/home )

• 1000 covid stories - people sharing their adverse reactions from the covid vaccine (https://1000covidstories.com/ )

• CDC study on 12- to 17-year-olds who got Pfizer vaccine: 397 reports of heart inflammation, 14 deaths (https://childrenshealthdefense.org/defender/cdc-397-reports-heart-inflammation-teens-pfizer-vaccine/ )

• Covid-19 vax reactions (https://www.c19vaxreactions.com/ )

• Latest CDC VAERS data for 12 to 17-year-olds include 7 deaths, 271 serious adverse events following COVID-19 vaccines (https://childrenshealthdefense.org/defender/cdc-vaers-data-deaths-adverse-events-covid-vaccines-including-children/ )

• Minnesota woman loses both legs and both hands following second Pfizer covid-19 shot (https://vaccineimpact.com/2021/minnesota-woman-loses-both-legs-and-both-hands-following-second-pfizer-covid-19-shot/ )

• Vaccine-damaged woman begs you to reconsider (https://www.bitchute.com/video/4Kmi7jO6RHgW/ )

• Wayne's COVID-19 vaccine injury story - I didn't know, nobody told me…& now I have brain damage! (https://www.bitchute.com/video/4pA7ALPuH1hc/ )

• Surgeon who operated on young Italian vaccine victim: 'You have never seen anything like this (https://freewestmedia.com/2021/06/27/surgeon-who-operated-on-young-italian-vaccine-victim-you-have-never-seen-anything-like-this/ )

• Women with life-altering injuries after the vaccine team up with U.S. senators to demand answers (https://childrenshealthdefense.org/defender/brianne-dressen-injuries-astrazeneca-covid-vaccine-senators-demand-answer/ )

• Real people who have been suffering after taking the COVID-19 injection (https://www.bitchute.com/video/AIh9pIFWjprb/ )

• 'Before the vaccine, my son was a healthy athlete. Now he can barely walk' (https://www.bitchute.com/video/gczKLPEebqMu/ )

• Teen who had a heart attack after covid vaccine tells Robert F. Kennedy Jr: 'I thought it was safe' (https://childrenshealthdefense.org/defender/isaiah-harris-rfk-jr-the-defender-podcast-teen-heart-attack-covid-vaccine/ )

• Preliminary finding of mRNA covid-19 vaccine safety in pregnant women (https://pubmed.ncbi.nlm.nih.gov/33882218/ )

• Julie & Ben - Bell's Palsy and neurological issues covid-19 vaccine reactions (https://www.bitchute.com/video/xOdXQUjGUFqI/ )

• Kevin's story - covid vaccine injuries (https://www.bitchute.com/video/pX6usSPg7CJo/ )

Other opinions reveal the disinformation about graphene oxide in vaccines.

Over 1000 published studies provide evidence that the COVID-19 "vaccines" are DANGEROUS

https://www.thecompleteguidetohealth.com/over-1000-published-studies-provide-evidence-that-the-covid-19-vaccines-are-dangerous.html

• Fact - deaths due to the covid vaccines in the UK after 6 months are 407% higher than deaths due to all other vaccines combined in the past 11 years (https://theexpose.uk/2021/07/11/fact-deaths-due-to-the-covid-vaccines-in-the-uk-after-6-months-are-407-higher-than-deaths-due-to-all-other-vaccines-combined-in-the-past-11-years/comment-page-1/ )

• 7-year-old dies 11 days after Pfizer shot, VAERS report shows (https://childrenshealthdefense.org/defender/vaers-cdc-child-dies-pfizer-covid-vaccine/ )

• 34,337 deaths and 3,120,439 injuries following COVID-19 shots in European database as UK public data show 35 deaths 213 hospitalizations among booster triple vaccinated. (https://vaccineimpact.com/2021/34337-deaths-3120439-injuries-following-covid-shots-in-european-database-as-uk-public-data-show-35-deaths-213-hospitalizations-among-booster-triple-vaccinated/ )

• 310 athlete cardiac arrests, serious issues, 177 dead, after covid shot (https://vaccineimpact.com/2021/310-athlete-cardiac-arrests-serious-issues-177-dead-after-covid-shot/ )

• A 5-year-old died 4 days after Pfizer shot, CDC VEARS data show (https://childrenshealthdefense.org/defender/vaers-cdc-adverse-events-deaths-5-year-old-died-pfizer-vaccine/ )

• 8-year-old girl has a stroke and brain hemorrhage 7 days after Pfizer covid-19 shot (https://vaccineimpact.com/2021/7-year-old-girl-has-stroke-and-brain-hemorrhage-7-days-after-pfizer-covid-19-shot/ )

• 120 teens hospitalized, 3 dead following Pfizer vaccine rollout for 15 to 17-year-olds in Vietnam (https://childrenshealthdefense.org/defender/teens-hospitalized-dead-pfizer-vaccine-vietnam/ )

• 2,620 dead babies in VAERS after covid shots… (https://vaccineimpact.com/2021/2620-dead-babies-in-vaers-after-covid-shots-more-fetal-deaths-in-11-months-than-past-30-years-following-all-vaccines-as-scotland-begins-investigation/ )

• 17-year-old develops multisystem inflammatory syndrome and myocarditis after Pfizer vaccine, report shows (https://childrenshealthdefense.org/defender/teen-multisystem-inflammatory-syndrome-myocarditis-pfizer-vaccine/ )

• 20-year-old loses her leg after second AstraZeneca jab in Surat Thani (https://www.nationthailand.com/in-focus/40007619 )

• 13-year-old boy loses eyesight 10 days after receiving the Pfizer covid-19 vaccine - mother seeks answers (https://thecovidworld.com/yassine-13-year-old-boy-loses-eyesight-10-days-after-receiving-the-pfizer-covid-19-vaccine-mother-seeks-answers/ )

• 14-year-old boy dies from massive brain bleed hours after receiving his second Pfizer covid-19 vaccine (https://thecovidworld.com/joshua-henry-14-year-old-boy-dies-from-massive-brain-bleed-hours-after-receiving-his-second-pfizer-covid-19-vaccine/ )

• A list of people who had their leg amputated after receiving the covid-19 vaccine (https://thecovidworld.com/a-list-of-people-who-had-their-leg-amputated-after-receiving-covid-19-vaccine/ )

• Footballer, 23, dead from jab MSM cover it up (https://brandnewtube.com/watch/ireland-footballer-23-dead-from-jab-msm-cover-it-up-hugo-talks-lockdown_vV5TwFZ9jtnbYlV.html )

• Mother of a 17-year-old girl who lost the use of her limbs after having the Pfizer vaccine (https://www.bitchute.com/video/3fmoAq8IfkPX/ )

• Stevie Thrasher, 29 years old from Washington, injured after receiving the Pfizer vaccine (https://www.bitchute.com/video/g859h1JZXW9B/ )

• 13-year-old dies in sleep after receiving Pfizer covid vaccine; CDC investigating (https://www.newsweek.com/13-year-old-dies-sleep-after-receiving-pfizer-covid-vaccine-cdc-investigating-1606529 )

• Dad: My son's school made him get a COVID-19 vaccine, and now he has a heart condition (https://childrenshealthdefense.org/defender/teen-heart-condition-pfizer-covid-vaccine-fabio-berlingieri-fox-friends/ )

• Laura Ingraham - interview with woman who suffered severe brain bleed after Moderna jab (https://www.bitchute.com/video/7QRLWTYsYxc2/ )

• Mother regrets putting 12-year-old daughter in Pfizer covid-19 vaccine trial (https://vaccineimpact.com/2021/former-nfl-player-collects-stories-of-lives-destroyed-by-the-covid-19-shots-mother-regrets-putting-12-year-old-daughter-in-pfizer-covid-19-vaccine-trial/ )

• 13-year-old Michigan boy dies three days after second dose of Pfizer vaccine, aunt says 'moral, ethical, health' questions need answers (https://childrenshealthdefense.org/defender/13-year-old-jacob-clynick-dies-pfizer-vaccine-myocarditis/ )

• Mum of three dies after receiving AstraZeneca coronavirus vaccine (https://www.walesonline.co.uk/news/uk-news/mum-three-dies-after-receiving-20914255 )

• Stephanie Wasil, 51, dies of cardiac arrest from the Moderna vaccine (https://www.bitchute.com/video/UceA3FGxtbJe/ )

• Family of Italian woman who died after Oxford AstraZeneca vaccine launches legal action (https://news.sky.com/story/covid-19-family-of-italian-woman-who-died-after-oxford-astrazeneca-vaccine-launches-legal-action-12278855 )

• Vietnamese woman dies after receiving AstraZeneca shot (https://www.chiangraitimes.com/thailand-national-news/news-asia/vietnamese-woman-dies-after-receiving-astrazeneca-vaccine-shot/ )

• Nurse develops Bell's Palsy after receiving covid jab (video) https://brandnewtube.com/watch/nurse-with-bell-039-s-palsy-three-weeks-after-taking-nwo-pfizer-vaxx_2y4i9CfrSeCjH8Z.html

• A 28-year-old mother from Wisconsin is brain dead after the second dose of the COVID injection https://vaccineimpact.com/2021/28-year-old-wisconsin-healthcare-worker-has-aneurysm-brain-dead-five-days-after-second-experimental-pfizer-mrna-covid-injection/

• 58-year-old woman dies hours after getting first dose of Pfizer vaccine https://childrenshealthdefense.org/defender/woman-dies-hours-after-first-dose-pfizer-vaccine/

• 19-year-old hospitalized with heart inflammation after covid vaccine https://www.jpost.com/health-science/19-year-old-hospitalized-with-heart-inflammation-after-pfizer-vaccination-657428

• 39-year-old nurse aide dies within 48 hours of receiving the COVID jab https://www.lifesitenews.com/news/39-year-old-nurse-aide-dies-within-48-hours-of-receiving-mandated-covid-19-shot

• A 41-year-old Portuguese mother of two who worked in pediatrics died at a hospital in Porto just two days after being vaccinated against covid-19 https://www.dailymail.co.uk/news/article-9111311/Portuguese-health-worker-41-dies-two-days-getting-Pfizer-covid-vaccine.html

• 63-year-old man dies 2 days after covid-19 vaccination - "it's too early to tell whether the jab was related to his death" (https://news.rthk.hk/rthk/en/component/k2/1578391-20210302.htm )

• 56-year-old woman dies days after covid vaccine - "no link established so far" (https://indianexpress.com/article/cities/delhi/gurgaon-woman-dies-days-after-covid-shot-officials-say-no-link-established-so-far-7158220/ )

• 88-year-old dies hours after covid vaccination in second such incident - "in both cases, medical professionals do not believe the deaths were connected to the vaccines" (https://www.jpost.com/israel-news/88-year-old-dies-hours-after-covid-vaccination-in-second-such-incident-653721 )

• Greek woman dies following AstraZeneca vaccine blood clot (https://greekreporter.com/2021/06/01/greek-woman-dies-following-astrazeneca-vaccine-blood-clot/ )

• Families of South Korea's covid vaccine victims mourn loved ones during mass memorial service (https://thecovidworld.com/families-of-south-koreas-covid-vaccine-victims-mourn-loved-ones-during-mass-memorial-service/ )

• Three footballers collapse in three days - (https://brandnewtube.com/watch/3-x-footballers-collapse-in-3-x-days-hugo-talks-lockdown_Eh8XQLJ79PQfFHe.html )

• Paul Dimattina: Australian football league legend rushed to hospital after sever reaction to Pfizer booster shot (https://thecovidworld.com/paul-dimattina-australian-football-league-legend-rushed-to-hospital-after-severe-reaction-to-pfizer-booster-shot/ )

• Sithipol Bovornkittipaisal: 26-year-old man dies 1 day after receiving Moderna covid-19 vaccine, investigation launched (https://thecovidworld.com/sithipol-bovornkittipaisal-26-year-old-man-dies-1-day-after-receiving-moderna-covid-19-vaccine-investigation-launched/ )

• As reports of injuries after covid vaccines near 1 million mark, CDC, FDA clear Pfizer, Moderna boosters for all adults (https://childrenshealthdefense.org/defender/vaers-cdc-injuries-covid-vaccines-fda-pfizer-moderna-bosters/ )

• How many people in key Pfizer covid vaccine trial died? More than Pfizer told you (https://childrenshealthdefense.org/defender/pfizer-six-month-data-update-covid-vaccine-clinical-trials/ )

• Pfizer secretly adds dangerous ingredient to injection for 5 to 11-year-olds as Taiwan stops Pfizer shots for 12 to 17-year-olds (https://vaccineimpact.com/2021/pfizer-secretly-adds-dangerous-ingredient-to-injections-for-5-to-11-year-olds-as-taiwan-stops-pfizer-shots-for-12-to-17-year-olds/ )

• Surge in reports of serious injuries as 5-year-olds start getting shots (https://childrenshealthdefense.org/defender/vaers-cdc-covid-vaccine-data-injuries-5-year-olds/ )

• German news agency compiles list of 75 European athletes who have died "suddenly" in the past 5 months since being fully vaccinated. (https://threadreaderapp.com/thread/1455320859753787396.html )

• Woman left wheelchair-bound with neurological damage hours after Pfizer vaccine dose (https://theexpose.uk/2021/11/10/woman-left-wheelchair-bound-with-neurological-damage-hours-after-pfizer-vaccine-dose/ )

• US Children's Hospitals Now Overwhelmed with Infant Cardiac Patients (https://theexpose.uk/2021/11/10/us-childrens-hospitals-now-overwhelmed-with-infant-cardiac-patients/ )

• Worldwide surge of sports people suffering sudden health issues and death (https://www.notonthebeeb.co.uk/post/surge-of-sports-people-worldwide-suffering-unexpected-ill-health )

• mRna shots are 'gene therapy' marketed as 'vaccines' to gain public trust says Big Pharma (https://brandnewtube.com/watch/mrna-shots-are-gene-therapy-marketed-as-vaccines-to-gain-public-trust-says-big-pharma-hugo-tal_6pKHdRnHeSRAPZ8.html )

• Pfizer adds ingredient used to stabilize heart attack victims in vax for kids (https://presscalifornia.com/2021/10/28/pfizer-vax-kids/ )

 

Other opinions dispute these articles.

Experts said that Covid-19 vaccines did not contain graphene or graphene oxide.

"No vaccines on the market [are] based on graphene oxide," Dr Park Jong-bo, a researcher at Biographene, a company that develops graphene-based medicine, told AFP.

The claim that commercially available vaccines were made up of graphene oxide is inaccurate, Professor Hong Byung-hee, an expert in nanomaterials at Seoul National University said.

Medtronic faces class-action lawsuit over diabetes data-sharing

Your health data is for sale. Even insulin pumps and CMG.

Medtronic faces class-action lawsuit over diabetes data-sharing: Mere months after Medtronic Diabetes resolved a 2021 FDA warning letter, it's in the hot seat again—now, as the subject of a class-action lawsuit.

According to the lawsuit, the affected data include those collected by the apps connected to Medtronic’s MiniMed insulin pumps and InPen “smart” insulin pens.

This information is protected by HIPAA regulations.   

Summary of the HIPAA Privacy Rule. 

There are stiff fines for negligence and/or wilfull abuse of HIPAA regulations

The U.S. Department of Health and Human Services (HHS) Office for Civil Rights (OCR) is responsible for enforcing the HIPAA Privacy and Security Rules. In cases of noncompliance where the covered entity does not satisfactorily resolve the matter, OCR may decide to impose civil money penalties (CMPs) on the covered entity. CMPs for HIPAA violations are determined based on a tiered civil penalty structure. The secretary of HHS has discretion in determining the amount of the penalty based on the nature and extent of the violation and the nature and extent of the harm resulting from the violation. The secretary is prohibited from imposing civil penalties (except in cases of willful neglect) if the violation is corrected within 30 days (this time period may be extended at HHS’ discretion). Penalties for civil violations range from $100 - $50,000 per violation, with an annual maximum of $25,000 for repeat violations¹³. 

In cases of willful neglect and is not corrected within required time period, the penalty range is $50,000 per violation, with an annual maximum of $1.5 million¹². 

I hope this helps!

Source: Conversation with Bing, 9/6/2023

(1) HIPAA violations & enforcement | American Medical Association. https://www.ama-assn.org/practice-management/hipaa/hipaa-violations-enforcement.

(2) The Most Common HIPAA Violations in the Workplace. https://factorialhr.com/blog/hipaa-violations-in-the-workplace/.

(3) HIPAA Violation Cases - Updated 2023 - HIPAA Journal. https://www.hipaajournal.com/hipaa-violation-cases/.

(4) HIPAA Violation Fines - Updated for 2023 - HIPAA Journal. https://www.hipaajournal.com/hipaa-violation-fines/.

Teen Dies Suddenly At Cheer Camp, Now Parents Are Raising Awarness About Her Cause Of Death - Opposing Views

A bright future was cut tragically short as a rising high school junior, Callie Mitchell, lost her life while attending a cheer camp at Texas A&M University. The 16-year-old, described as a ray of sunshine, was airlifted to Texas Children's Hospital after a coach performed CPR on campus. Despite the valiant efforts to save her, Mitchell's life came to a heartbreaking end.

Heartbreakingly, Mitchell's father, Scott Donahue, revealed that his daughter had long QT syndrome, a cardiac conduction disorder that disrupts the heart's electrical rhythm. Often inherited, this condition can lead to sudden cardiac arrest. Scott believes that the condition likely triggered her cardiac arrest, underscoring the importance of early detection.

Notably, long QT syndrome can be detected through an electrocardiogram (EKG), a test not included in the standard athletic physicals provided to students in Texas. In light of their devastating loss, Mitchell's father is passionately advocating for parents to ensure their children receive EKG screenings.

"For any other parents out there, you know they do physical tests every year. ... EKGs are not part of a physical test. ... Get an EKG," Scott asserted, stressing the potential life-saving impact of this preventive measure.

Tragedy has struck, but in the midst of heartache, a mission emerges. Callie Mitchell's story stands as a reminder that advocating for early detection and proactive health measures can save lives. As the community mourns the loss of this bright soul, her legacy serves as a call to action, urging parents to take an extra step in safeguarding their children's well-being.

FOX NEWS

There have been accounts of sudden death or cardiac arrest in young athletes following the COVID 19 pandemic.

It is known that COVID 19 victims often have heart inflammation from either the disease or vaccination with the mRNA vaccine.

If someone had Covid or the vaccine, it is prudent to have an EKG as part of the pre-physical examination prior to participating in vigorous exercise.

Myocarditis and Pericarditis after COVID-19 Vaccination

Myocarditis and pericarditis after COVID-19 vaccination are rare. Myocarditis is inflammation of the heart muscle, and pericarditis is inflammation of the outer lining of the heart. Most patients with myocarditis or pericarditis after COVID-19 vaccination responded well to medicine and rest and felt better quickly, and most cases have been reported after receiving mRNA COVID-19 vaccines.

VAERS reports

Teen Dies Suddenly At Cheer Camp, Now Parents Are Raising Awarness About Her Cause Of Death - Opposing Views

The Path to Longevity

 

In our last Health Train Express we discussed the 'Blue Zone"

Today's followup is with Peter Attia, M.D.  Dr. Attiaa is a well known established authority on health and wellness.  

From June 2001 to July 2006 Dr. Attia specialized in Surgical oncology at the Johns Hopkins Hospital in Baltimore, Maryland.^[4] During this time, he also undertook research at the NIH in Bethesda, Maryland, focusing on cancer immunotherapy for melanoma.^[5]  

During this time he became aware of the importance of optimal nutrition treating cancer patients.

In 2014 he founded a private clinic dedicated to longevity medicine.[7 

twitter.com/PeterAttiaMD

Peter Attia Podcast

Peter Attia YouTube

The Blue Zone Phenomenon

The burden of chronic illness weighs heavily upon our society, government health programs, hospitals and other health providers.

Roughly 18% of our GDP is used for health care.  It is draining our national wealth as much as national defense.

Is there an immediate solution?  No there is no ' mRNA vaccine' that will eliminate chronic illness.  Most chronic illnesses have a common denominator.  It is not poverty or wealth.  Chronic illness is prevalent among the rich and poor of America, and other nations.

Let us begin

The term “Blue Zone” is attributed to journalist Dan Buettner who authored an article for National Geogrphic Magazine .

Dan Buettner is an American explorer, National Geographic Fellow, journalist, and author best known for his work on the "Blue Zones," which are areas around the world where people live longer and healthier lives compared to other regions. Dan Buettner is an explorer, National Geographic Fellow, award-winning journalist and producer, and New York Times bestselling author. He discovered the five places in the world – dubbed blue zones hotspots – where people live the longest, healthiest lives. His articles about these places in The New York Times Magazine and National Geographic are two of the most popular for both publications. The concept of Blue Zones came out of his work with National Geographic and the scientific community to identify and study the areas with the highest concentrations of centenarians (people who live to or past the age of 100).

Buettner has written several books on the subject, including "The Blue Zones: Lessons for Living Longer from the People Who've Lived the Longest," where he examines communities in places like Okinawa, Japan; Sardinia, Italy; and Loma Linda, California. His work has gained attention for its insights into longevity, health, and happiness, and has been influential in public health discussions about what factors contribute to a long and healthy life.

He has also applied his research to public initiatives and programs aimed at improving community health and well-being. The "Blue Zones Project" is one such initiative, aimed at applying lessons from the Blue Zones to communities across the United States.

It's worth noting that my information might be outdated, and you may want to check for the most current information on Dan Buettner's work.

The term "Blue Zones" refers to geographic areas where people are observed to live longer, healthier lives, often reaching 100 years of age at significantly higher rates compared to other regions. The concept gained mainstream attention after being popularized by Dan Buettner, an explorer and journalist who wrote about these zones in a cover story for National Geographic magazine and later in a series of books.

The Blue Zones identified by Buettner and his team of researchers are:

1. **Okinawa, Japan** - Known for a large population of centenarians, particularly among women. The traditional diet is rich in vegetables, tofu, and seafood.

  2. **Sardinia, Italy** - Particularly a region in the mountainous areas of the island, where men are known for their longevity. The diet includes whole grains, fruits, vegetables, and small amounts of meat and dairy.

2. **Sardinia, Italy** - Particularly a region in the mountainous areas of the island, where men are known for their longevity. The diet includes whole grains, fruits, vegetables, and small amounts of meat and dairy.

3. **Nicoya Peninsula, Costa Rica** - Known for its population's high life expectancy, which is attributed to a diet rich in tropical fruits, beans, and corn, as well as strong social and family ties.

4. **Ikaria, Greece** - An island in the Aegean Sea where people live longer, often free from common diseases that affect the rest of the Western world. The diet is rich in fruits, vegetables, whole grains, and olive oil.

5. **Loma Linda, California, USA** - Known for a community of Seventh-day Adventists, who outlive their American counterparts by several years, largely due to dietary restrictions (often vegetarian), regular exercise, and strong social and spiritual practices.

Several common threads run through the lifestyles of people in these Blue Zones:

1. **Diet** - Mostly plant-based, rich in fruits, vegetables, and whole grains.

  2. **Physical Activity** - Regular, moderate exercise often incorporated naturally into daily life, such as walking or gardening.

  3. **Social Engagement** - Strong social networks, often involving multigenerational households or community involvement.

4. **Stress Management** - Strategies for reducing stress, which can include prayer, meditation, naps, or social engagement.

5. **Purpose** - A sense of purpose and community belonging, often articulated through specific cultural practices or spiritual beliefs.

It's worth noting that while the Blue Zones offer interesting insights into lifestyle and longevity, they are not "prescriptions" for long life. Rather, they offer observations that can be applied in different contexts for potentially enhancing health and well-being.

Glossary

1. **Blue Zones**: Geographic areas where people live exceptionally long, healthy lives often marked by higher rates of centenarians compared to other regions.

2. **Centenarian**: An individual who has reached the age of 100 years or more.

3. **Life Expectancy**: The average number of years a person is expected to live, based on statistical averages.

4. **Longevity**: The long duration of individual life.

### Geographic Locations

1. **Okinawa**: An island in Japan known for the long lifespan of its inhabitants, particularly among women.

2. **Sardinia**: An island in Italy, specifically the mountainous regions where men are known for their longevity.

3. **Nicoya Peninsula**: A region in Costa Rica known for high life expectancy rates.

4. **Ikaria**: An island in Greece known for the longevity of its inhabitants.

5. **Loma Linda**: A city in California, USA, where a community of Seventh-day Adventists is known for living longer than the average American.

### Lifestyle Factors

1. **Plant-Based Diet**: A diet primarily made up of plant foods such as fruits, vegetables, grains, and legumes.

2. **Moderate Exercise**: Physical activity that is not overly strenuous but sufficient to maintain health, often integrated into daily life.

Glossary

 

1. **Blue Zones**: Geographic areas where people live exceptionally long, healthy lives often marked by higher rates of centenarians compared to other regions.

2. **Centenarian**: An individual who has reached the age of 100 years or more.

3. **Life Expectancy**: The average number of years a person is expected to live, based on statistical averages.

4. **Longevity**: The long duration of individual life.

### Geographic Locations

1. **Okinawa**: An island in Japan known for the long lifespan of its inhabitants, particularly among women.

2. **Sardinia**: An island in Italy, specifically the mountainous regions where men are known for their longevity.

3. **Nicoya Peninsula**: A region in Costa Rica known for high life expectancy rates.

4. **Ikaria**: An island in Greece known for the longevity of its inhabitants.

5. **Loma Linda**: A city in California, USA, where a community of Seventh-day Adventists is known for living longer than the average American.

### Lifestyle Factors

1. **Plant-Based Diet**: A diet primarily made up of plant foods such as fruits, vegetables, grains, and legumes.

2. **Moderate Exercise**: Physical activity that is not overly strenuous but sufficient to maintain health, often integrated into daily life.

3. **Social Network**: A web of relationships and social interactions that can offer emotional or material support.

4. **Multigenerational Households**: Families where more than two generations live together, often providing social and emotional support.

5. **Stress Management**: Techniques or lifestyle choices aimed at reducing or managing stress.

### Cultural and Spiritual Practices

1. **Purpose**: A sense of meaning in life, often related to work, community, or spiritual belief.

2. **Meditation**: A practice aimed at focusing the mind and reducing stress.

3. **Seventh-day Adventist**: A Christian denomination known for a specific lifestyle that includes Sabbath observance, a healthful diet, and a focus on community.

### Nutritional Terms

1. **Whole Grains**: Grains that include the entire grain kernel, which are more nutritious and beneficial for health compared to refined grains.

2. **Tofu**: A food made from soybeans, commonly consumed in Asian diets like Okinawa's.

3. **Olive Oil**: A type of oil high in monounsaturated fats, commonly used in Mediterranean diets like Ikaria's.

4. **Legumes**: A family of plants whose seeds are eaten, including lentils, chickpeas, and various types of beans.

Understanding these terms can provide a foundational knowledge of what makes the Blue Zones special and how their lifestyle choices contribute to longevity and better quality of life.

No article is credible without opposing views.

FDA Decisions 2023: New FDA Approvals for Sandoz, Gilead Sciences and More | BioSpace

The FDA was on a roll in the first half of 2023, approving more than two dozen novel treatments. 

And if the first six months is any indication, the biopharma industry should expect several more novel therapies to be greenlit, including a few more first-in-class treatments. But it’s not always good news that companies have to deliver to their stakeholders; the year has already seen its fair share

Aug 24: 

Sandoz, the generics and biosimilars arm of Novartis, has earned FDA approval for the first biosimilar drug to treat multiple sclerosis. Tyruko (natalizumab-sztn) is a biosimilar of Biogen’s treatment Tysabri (natalizumab), a monotherapy used to treat adults with relapsing forms of MS. The biosimilar is also approved to treat adults with Crohn’s disease, another approved indication for Tysabri. Both drugs come with the risk of opportunistic viral infection progressive multifocal leukoencephalopathy and will carry a boxed warning about the potentially severe complication.  

Aug 24: 
Gilead Sciences’ antiviral drug Veklury (remdesivir) earned a label expansion from the FDA, now cleared for COVID-19 patients with all stages of liver disease. The dose will be the same as it was for its originally approved uses in adult and pediatric patients with mild to moderate COVID-19 who are at high risk for progression to severe COVID-19. Veklury was the first drug to get full FDA approval for COVID-19. In July, the FDA approved another supplemental NDA that allowed it to be used across all stages of renal disease. 
The FDA based its expansion for all stages of liver disease on the data from a Phase I trial that showed no new safety signals. Hepatic laboratory testing is recommended for all patients and the drug may need to be discontinued if alanine transaminase levels hit 10 times the high end of the normal range or liver inflammation develops. 

Aug 21:
Pfizer’s respiratory syncytial virus vaccine Abrysvo won FDA approval for use in pregnant women to prevent RSV-associated lower respiratory tract disease in infants. Abrysvo is an unadjuvanted bivalent RSV prefusion F vaccine composed of two proteins that were selected specifically to optimize against the RSV A and B strains.
The vaccine was first approved in June 2023 for use in adults aged 60 years and above. However, the shot can now also be administered to pregnant women at 32 through 36 weeks of gestation to elicit immunity in their infants.
Data from the Phase III MATISSE trial supported the FDA’s approval. At the study’s prespecified interim analysis, Abrysvo had a vaccine efficacy of 81.8% for preventing medically attended severe RSV-associated lower respiratory tract disease (LRTD) 90 days after birth. This waned slightly to 69.4% at 180 days. The findings were published in The New England Journal of Medicine in April 2023.

Aug 18:
Neurocrine Biosciences got FDA approval to expand Ingrezza’s (valbenazine) label to include chorea in Huntington’s disease. Approved in 2017 to treat tardive dyskinesia, Ingrezza is a selective vesicular monoamine transporter 2 inhibitor.
In the company’s supplemental NDA, Neurocrine included data from the Phase III KINECT-HD trial and the ongoing KINECT-HD2 open-label study to establish the safety and efficacy of Ingrezza in the proposed indication. Data in a Lancet Neurology publication in May showed that Ingrezza treatment significantly reduced scores in the Unified Huntington’s Disease Rating Scale Total Maximal Chorea score by 3.2 units versus placebo, an effect that was statistically significant.
Ingrezza also outperformed placebo on secondary endpoints, including the Clinical Global Impression of Change and Patient Global Impression of Change response status. In clinical studies of Huntington’s disease, treatment-emergent adverse events included somnolence and sedation, urticaria, rash and insomnia.

Aug 18:
Regeneron Pharmaceuticals’ Veopoz (pozelimab) secured FDA approval as the first and only treatment indicated specifically for CHAPLE disease, also known as CD55-deficient protein-losing enteropathy, an ultra-rare hereditary disease that can cause potentially life-threatening gastrointestinal and cardiovascular symptoms. A fully human monoclonal antibody, Veopoz is approved for the treatment of adult and pediatric CHAPLE patients 1 year of age and older.
In February 2023, the FDA gave Priority Review to Regeneron’s investigational antibody, which works by binding to the C5 complement factor, thereby disrupting the complement cascade and preventing associated diseases. Regeneron presented Phase II/III data in its application for regulatory approval showing “rapid and sustained normalization” of albumin, one of the key markers of CHAPLE disease, in all 10 patients at 24 weeks. The treatment also eased symptoms such as increased bowel movements and abdominal pain.

Aug 18:
The FDA has expanded the label of Regeneron’s blockbuster eye therapy Eylea (aflibercept), allowing the administration of a higher 8-mg dose. Under the new high-dose regimen, Eylea injections will be given every four weeks for the first three months across all indications.
In diabetic retinopathy, the treatment can be administered every eight to 12 weeks thereafter, while the dosing interval can stretch up to 16 weeks in patients with wet age-related macular degenerationand diabetic macular edema. Eylea was previously approved in these indications but was limited to 2-mg doses.

Aug 16:
After two prior setbacks, Ipsen’s palovarotene finally earned FDA approval to treat fibrodysplasia ossificans progressive (FOP), the first treatment for the ultra-rare bone disease. Now to be sold under the brand name Sohonos, the oral medication is indicated for the reduction of heterotrophic ossification in adults and children with FOP.
The FDA approval is the culmination of a long and bumpy road for Ipsen’s FOP drug. The biotech first tried for an approval in 2021 but voluntarily withdrew its application in August of that year after the regulator asked for more data. Ipsen filed a resubmission a few months later, which the FDA rejected in December 2022 and requested additional information regarding the data that the company had already provided.
The FDA’s approval this week was backed by data from the Phase III MOVE trial, which according to Ipsen is the first and largest multicenter, open-label study in this space involving both adult and pediatric patients. In the trial, palovarotene reduced the annualized heterotrophic ossification by 54% compared with standard of care without introducing new safety signals. 

Aug 14:
Following a nearly decade-long effort, Delcath Systems finally won the FDA’s greenlight for its Hepzato Kit for the liver-directed treatment of adult patients with metastatic uveal melanoma. Hepzato is a drug-device combination of melphalan—a well-established chemotherapeutic agent—and the company’s Hepatic Delivery System, which can directly administer the drug to the liver.
Delcath first sought FDA approval in August 2012. More than a year later, in September 2013, the regulator rejected the application, asking the company to perform another well-controlled randomized trial to better determine the safety and efficacy of the investigational product. In February 2023, nearly 10 years later, Delcath resubmitted its NDA.
The application contained data from the Phase III FOCUS study, a single-arm, open-label trial which enrolled 91 patients who were treated every six to eight weeks for up to a maximum of six cycles. FOCUS found that the drug-device combination had an overall response rate of 36.3%, including seven complete responders and 26 partial responders, with treatment response lasting for a median of 14 months. Patients treated with Hepzato saw a 73.6% disease control rate.

Aug 14:
In what is expected to become a multibillion-dollar blockbuster, Pfizer’s BCMAxCD3 bispecific antibody Elrexfio (elranatamab-bcmm) has secured an FDA accelerated approval as another off-the-shelf treatment option for patients with relapsed or refractory multiple myeloma (RRMM) who have received at least four prior lines of therapy. Elrexfio is being touted by Pfizer as the first off-the-shelf, ready-to-use fixed-dose subcutaneous therapeutic that targets the BCMA protein.
The FDA’s accelerated approval was supported by data from the Phase II MagnetisMM-3 study, which found that in heavily pretreated RRMM patients who had not yet received BCMA-directed therapy, Elrexfio had an overall response rate of 58%, with around 82% of responders maintaining improvements for at least nine months. In those with prior exposures to BCMA-directed therapies, Elrexfio elicited an overall response rate of 33%. The therapy comes with a boxed warning for cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome.

Aug 14:
Biotech company Revance Therapeutics has received its first therapeutic indication for Daxxify (daxibotulinumtoxinA-lanm) for the treatment of cervical dystonia in adults. Revance won approval based on data from the Phase III ASPEN 1 and ASPEN OLS trials in which Daxxify was found to be safe and effective at two separate injected doses with a median duration of effect of 24 and 20.3 weeks for the respective groups.
Daxxify, a neuromuscular blocking agent and acetylcholine release inhibitor that’s positioned as a rival to AbbVie’s Botox, was approved in September 2022 for the temporary improvement of moderate to severe frown lines in adults. According to Revance, the total U.S. therapeutic neuromodulator market opportunity for Daxxify is $2.5 billion, including the $345 million cervical dystonia market.

Aug 11:
J&J’s Janssen got the FDA’s greenlight for its PARP inhibitor Akeega (niraparib and abiraterone acetate), which is now authorized to treat BRCA-mutated metastatic castration-resistant prostate cancer. Akeega is the first dual-action tablet that combines the activity of a PARP inhibitor with abiraterone acetate, an androgen biosynthesis inhibitor sold by the company under the brand name Zytiga.
The approval covers a combination regimen of Akeega with prednisone and is based on data from the Phase III MAGNITUDE study, a randomized, double-blinded and placebo-controlled trial with 765 participants. Compared with Zytiga plus prednisone, the Akeega-based regimen significantly improved radiographic progression-free survival by 47% in BRCA-positive patients.

Aug 10:
Janssen also won the FDA’s accelerated approval for its first-in-class bispecific T cell engager Talvey (talquetamab) as a treatment for relapsed or refractory multiple myeloma. By targeting both the CD3 and the GPRC5D proteins, Talvey works by bringing together T cells and myeloma cells, allowing the body’s immune system to exert its anti-cancer effects.
The accelerated approval was based on a Phase II study in which an overall response rate of 73.6% was seen in patients with at least four prior lines of therapy. Response was durable for a median of 9.5 months in the lower dosing group. Median duration of response was not yet reached in the higher dose arm. Like Pfizer’s Elrexfio, Talvey comes with a boxed warning for cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome.

Aug 9:
Nearly three years after first winning accelerated FDA approval of Gavreto (pralsetinib) in metastatic non-small cell lung cancer (NSCLC) with RET fusions, Genentech (Roche) and Blueprint Medicines announced the drug’s conversion to full approval.
RET fusions are present in just 1-2% of NSCLC cases, according to Genentech. The original FDA nod was based on an overall response rate (ORR) of 57% and median duration of response (DoR) that had not yet been reached in 114 patients in the Phase I/II ARROW study. The conversion to traditional approval was granted based on an additional 123 patients and 25 months of further follow-up. Treatment-naïve patients saw a median DoR of 13.4 months with a 78% ORR, while patients previously treated with platinum-based chemotherapy had an ORR of 63% and DoR of 38.8 months.

Aug 9:
Shares of Galera Therapeutics plummeted more than 80% Wednesday after the FDA rejected the company’s application for avasopasem manganese (avasopasem). The drug was being proposed to treat severe oral mucositis (SOM)—or mouth sores—resulting from radiotherapy in patients with head and neck cancer.
In its Complete Response Letter, FDA said results from the Phase III ROMAN trial, in combination with the GT-201 trial, were “not sufficiently persuasive to establish substantial evidence of avasopasem’s effectiveness and safety” in reducing these mouth sores. Galera will need to provide results from an additional clinical trial in order to resubmit the application, the Malvern, Penn–based company said in a press release. Impacts for the company’s workforce were swift, as Galera announced it would reduce its numbers by approximately 70% in order to extend its cash runway.
Aug 4:

In another milestone moment, the FDA approved Biogen and Sage Therapeutics’ zuranolone—henceforth Zurzuvae—as the first pill for postpartum depression (PPD). Zurzuvae is only the second treatment for this indication and the first pill that can be taken at home. The drug—a neuroactive steroid that works as a positive allosteric modulator of GABA-A receptors—also acts much more quickly than other approved depression treatments, with improved symptoms seen in trials in as few as three days.
Despite the significance of the approval, Sage and Biogen had sought a much larger slice of the depression market, but this will have to wait as the FDA rejected zuranolone for the treatment of major depressive disorder (MDD). In its Complete Response Letter, the FDA stated that the application did not provide “substantial evidence of effectiveness” to support its approval and that further research would be required. On a conference call following the decision, Sage CEO Barry Greene said only that the companies are “reviewing the feedback and evaluating next steps.”

Aug 4:
Mesoblast will have to provide more data before the FDA may approve its BLA for remestemcel-L for the treatment of pediatric steroid-refractory acute graft versus host disease (SR-aGVHD). In response to the FDA’s complete response letter (CRL), announced Friday by Mesoblast, the New York–based biopharma will “conduct a targeted, controlled study in the highest-risk adults with the greatest mortality.” Mesoblast noted that the adult study is in line with its overall commercial strategy, which involves a progression from pediatric to adult SR-aGVHD indications. This is the second rejection for remestemcel-L, after the FDA first turned down Mesoblast’s application in 2020, despite a 9-1 advisory committee vote in its favor.

Aug 3:
In 2019, the FDA approved the first vaccine for Ebola, a deadly viral hemorrhagic fever, for adults 18 years and older. Now, that vaccine—Ervebo, developed by Merck—is available to children 12 months and older. The FDA’s decision follows a recommendation on July 20 by the European Medicines Agency's Committee for Medicinal Products for Human Use to expand Ervebo’s label to children one year and older. The vaccine is only FDA-approved to protect against the Zaire ebolavirus and not other species of Ebola or Marburgvirus and the duration of protection is unknown, according to Merck.
Aug 2:
Taiho Oncology picked up a label expansion for its cancer drug Lonsurf (tipiracil), alone or as part of a combination regimen with Roche’s Avastin (bevacizumab) in metastatic colorectal cancer (mCRC). The nod came nearly eight years after Lonsurf first won approval as a monotherapy for mCRC in Sept. 2015. The expansion pertains to patients who had previously been treated with an anti-VEGF biologic agent and fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy. Patients whose cancer has the wild-type RAS protein and who have previously received an anti-EGFR therapy are also eligible for the new combination.
The FDA’s decision was supported by the Phase III SUNLIGHT trial, where the Lonsurf–Avastin combination led to a median overall survival of 10.8 months versus 7.5 months on Lonsurf monotherapy, for a 39% reduction in risk of death.

July
July 31:
GSK’s Jemperli (dostarlimab-gxly) won FDA approval as a frontline treatment for primary advanced or recurrent endometrial cancer. The regulatory nod is the first new frontline treatment for patients whose cancer is mismatch repair deficient (dMMR) or microsatellite instability-high (MSI-H) in decades, according to GSK. Jemperli is also the first immuno-oncology treatment and PD-1 inhibitor to be authorized for frontline use in this patient population.
Jemperli, an anti-PD-1 antibody, was first approved in April 2021 for recurrent or advanced dMMR endometrial cancer. The FDA accepted the supplemental BLA to move the drug into the frontline setting on June 6 and set a target action date of Sept. 23, meaning Monday’s approval came nearly two months ahead of schedule.

July 29:
Citius Pharmaceuticals’ plans to bring a reformulated version of Eisai’s withdrawn cancer drug Ontak were put on hold on Saturday after the FDA rejected its BLA for Lymphir (denileukin diftitox). Citius acquired the drug from Dr. Reddy's Laboratories in Sept. 2021.
An engineered IL-2-diphtheria toxin fusion protein being developed to treat relapsed or refractory cutaneous T-cell lymphoma (CTCL), Lymphir specifically binds to IL-2 receptors to precisely deliver its toxic payload, thereby preventing protein synthesis in malignant T cells. The drug also targets the immunosuppressive regulatory T cells, which allows the body to mount a stronger immune response against the cancer.
In its announcement of the Complete Response Letter, Citius said the FDA will require it to “incorporate enhanced product testing and additional controls” into the BLA. No clinical efficacy or safety issues were raised and Citius stated it will continue working toward FDA approval of Lymphir.  

July 28:
The FDA approved RiVive, a 3 milligram (mg) naloxone hydrochloride nasal spray manufactured by Harm Reduction Therapeutics, as the second over-the-counter (OTC) naloxone rescue option for opioid overdose. The approval comes just four months after the regulator greenlit Narcan, a 4-mg naloxone hydrochloride nasal spray, as the first OTC naloxone product. Narcan is manufactured by Emergent BioSolutions. Naloxone rapidly reverses the effects of opioid overdose—a long-running epidemic that claimed the lives of more than 105,000 people in the U.S. in the year ending in February 2023, according to the FDA.
In a press release announcing RiVive’s approval, FDA Commissioner Robert Califf stated the regulator’s commitment to making naloxone accessible and encouraged other manufacturers of these products to discuss potential nonprescription development programs with the FDA.

July 26:
Octapharma secured approval for Balfaxar (prothrombin complex concentrate) for the reversal of the blood-thinner Warfarin in emergency surgery and invasive procedures. Warfarin increases the risk of bleeding—a serious complication during surgery. Balfaxar works to quickly increase blood levels of key clotting factors and antithrombotic proteins. A lyophilized powder, it is reconstituted in a device developed by Octapharma.
While Balfaxar met the primary endpoint of hemostatic efficacy in a Phase III study and was non-inferior to the comparator, Kcentra, fatal and non-fatal arterial and venous thromboembolic complications were observed in clinical trials and post-marketing studies, and healthcare providers are advised to monitor patients for signs of thromboembolic events.
The approval is the third for Balfaxar, which is already marketed in Canada and the EU as octaplex.

July 25:
People with an eyelid disease called demodex blepharitis now have a treatment option as the FDA approved Tarsus Pharmaceuticals’ Xdemvy. A prescription eyedrop, Xdemvy aims to eradicate the root cause of the disease—demodex mites that burrow in the eyelash follicles of sufferers. Xdemvy is the first therapy approved for the condition. 
Approval for Xdemvy was granted based on two randomized, multicenter, double-masked, vehicle-controlled studies of 833 patients, in which 415 patients received the treatment. A significant improvement was seen in each study by day 43, Tarsus stated in its approval announcement, adding that the therapy was “generally safe and well-tolerated.” 
Tarsus will have a significant market for Xdemvy as demodex blepharitis affects around 25 million people in the U.S. and accounts for more than two-thirds of all blepharitis cases, according to Tarsus. 

July 24:
The FDA has approved the first treatment for adults and children two years and older with molluscum contagiosum, a viral skin infection that affects around 6 million people in the U.S. every year.  A topical solution developed by Verrica Pharmaceuticals, YCANTH is a drug-device combination that contains a GMP-controlled formulation of cantharidin, a substance derived from the blister beetle Cantharis vesicatoria. It works by causing a blister to form on the wart or growth, eventually lifting it off the skin. 
YCANTH’s approval is based on data from two randomized, double-blind, multicenter Phase III trials. In each trial, a clinically and statistically significant number of patients treated with YCANTH achieved complete clearance of all treatable molluscum lesions, meeting the primary endpoint. No serious adverse reactions were reported in either trial. The company expects to make YCANTH available to patients and caregivers by September, Ted White, Verrica’s president and CEO, said in a statement.

July 20:
Four years after it was rejected by the FDA due to safety concerns, Daiichi Sankyo’s Vanflyta (quizartinib) won approval to treat patients with acute myeloid leukemia that has a FLT3-ITD gene mutation. In 2019, an FDA advisory committee voted that the benefit conferred by quizartinib did not outweigh the safety risks. Thursday’s approval comes with a Boxed Warning for three heart disorders: QT prolongation, torsades de pointes and cardiac arrest, and will only be available through a restricted Risk Evaluation and Mitigation Strategy (REMS) program.
Daiichi Sankyo supported its NDA, accepted last Fall, with data from a Phase III trial that showed the quizartinib regimen—combined with standard induction and consolidation chemotherapy and continued as a single agent)—reduced the risk of death by 22.4% compared to patients on chemotherapy alone. After 39.2 months of follow-up, quizartinib more than doubled the overall survival advantage, the company stated in a press release.

July 20:
Emergent BioSolutions secured approval for Cyfendus, a vaccine intended for use after exposure to bacillus anthracis, a bacterium that causes anthrax. Cyfendus is required to be used in combination with “recommended” antibacterial drugs, according to Emergent’s announcement. The approval was based on a series of studies, including a pivotal Phase III trial assessing the vaccine’s consistency, immunogenicity and safety in healthy adults. Even before the approval, Emergent had been supplying Cyfendus to the U.S. Department of Health and Human Services under pre-Emergency Use Authorization for four years. 

July 17:
Infants and children at severe risk of RSV have another treatment option after the FDA approved Sanofi and AstraZeneca’s Beyfortus (nirsevimab). A monoclonal antibody, Beyfortus is just the second RSV drug authorized in the U.S. for high-risk children, the other being Synagis (palivizumab), which was approved in 1998. The companies’ bid for approval was backed by three late-stage trials that demonstrated the antibody’s safety and efficacy. Beyfortus will be available in the U.S. ahead of the 2023/2024 RSV season for children entering their first RSV season and those at severe risk up to 24 months, Sanofi stated in a press release.

July 13:
The FDA approved Perrigo Company’s Opill (norgestrel)—a progestin-only daily oral contraceptive—as the first-ever birth control pill available over the counter in the U.S. Perrigo expects Opill to be available online and in-person at drug stores, convenience stores and grocery stores in the first quarter of 2024. In a prepared statement, Perrigo President and CEO Patrick Lockwood-Taylor said the approval “marks a truly momentous day for women's health

 nationwide.” 
July 6:
A short workweek in the U.S. ended with big news as the FDA granted traditional approval to the first anti-amyloid antibody—and the first disease-altering drug—for Alzheimer’s disease. The accelerated approval for Eisai and Biogen’s Leqembi (lecanemab) was converted to a full approval based on results from the confirmatory Clarity-AD trial, which the FDA said in its statement verified the drug’s benefit. With the approval, Medicare coverage for Leqembi is expected to begin right away, with the requirement of a patient registry intended to collect further information on the effectiveness of this drug class in Alzheimer’s. 

July 3:
Amneal Pharmaceuticals received a Complete Response Letter for IPX203—a novel oral formulation of carbidopa/levodopa (CD/LD), a well-established combination for the management of Parkinson’s disease. In its rejection letter, the FDA said that while Amneal was able to adequately establish the safety of levodopa, it was not able to sufficiently do so for carbidopa. The regulator has requested additional pharmacokinetic data. The New Jersey–based company stated it plans to meet with the FDA to determine the best path forward for the treatment.

June
June 29:
Capping a busy week, the FDA approved BioMarin’s Roctavian (valoctocogene roxaparvovec-rvox) as the first gene therapy for adults with severe hemophilia A. Hemophilia is a rare genetic bleeding disorder caused by a mutation in the gene that encodes factor VIII (FVIII), which is necessary for blood to clot. A one-time gene therapy, Roctavian contains a healthy gene for factor VIII. Delivered through an adeno-associated virus (AAV) vector, the gene is expressed in the liver to increase blood levels of FVIII, thereby reducing the risk of uncontrolled bleeding. 

June 28:
The FDA notched another milestone with the approval of the first cellular therapy for type 1 diabetes. Lantidra (donislecel) developed by Chicago-based CellTrans, is a cell therapy made from the pancreatic islet cells of deceased donors. It is intended for adult patients whose repeated hypoglycemic episodes leave them unable to hit average blood glucose levels. In a clinical trial of 30 patients, 21 were insulin-free for at least a year; 11 didn’t require insulin for between one and five years and 10 were insulin-free for more than five years. Five patients failed to achieve any days of insulin independence.

June 28:
Pfizer’s bet on OPKO Health’s human growth hormone analog paid off as the FDA approved the treatment—which will be marketed as Ngenla—to treat children whose production of growth hormones is impaired. Pfizer purchased exclusive global commercialization rights for the then-experimental treatment in December 2014 for $295 million upfront and a promise of up to $275 million in milestones. This was the partners’ second try for FDA approval after the regulator rejected Ngenla’s first bid in January 2022. Pfizer and OPKO did not state the reasons for the initial denial.

June 28:
The FDA declined to approve Eton Pharmaceuticals’dehydrated alcohol injection for the treatment of methanol poisoning, citing concerns related “primarily to Chemistry Manufacturing and Controls.” This is the second Complete Response Letter issued to Eton for this proposed treatment. In the first, issued in March 2021, the FDA indicated that travel restrictions due to the COVID-19 pandemic prevented a timely inspection of the company’s European contract manufacturing site.

June 27:
The FDA approved UCB’s Rystiggo (rozanolixizumab), a subcutaneously administered humanized IgG4 monoclonal antibody, to treat generalized myasthenia gravis, a rare muscle-wasting autoimmune disease. Rystiggo is the only treatment approved to treat patients who are anti-acetylcholine receptor- or anti-muscle-specific tyrosine kinase antibody-positive. The regulatory green light was based on a Phase III trial that showed Rystiggo led to significant improvements in symptoms related to breathing, talking, swallowing and rising from a chair.

June 23:
The FDA greenlit Pfizer’s Litfulo (ritlecitinib) for the treatment of patients as young as 12 years with severe alopecia areata, an autoimmune disease characterized by patchy or complete hair loss on the scalp, face or body. Litfulo inhibits Janus kinase 3 and the tyrosine kinase and is believed to work by blocking the signaling of cytokines and cytolytic activity of T cells, which are implicated in alopecia areata.

June 22: 
In one of the year’s most-anticipated regulatory decisions, the FDA approved Sarepta’s Elevidys—formerly SRP-9001—for children 4 to 5 years with Duchenne muscular dystrophy. Elevidys is the first-ever gene therapy for DMD, a neuromuscular disease characterized by progressive muscle weakness and atrophy that strikes primarily young boys. The gene therapy was approved via the FDA’s accelerated approval pathway based on data that established it increased the expression of the Elevidys micro-dystrophin protein.

June 21:
Eli Lilly and Boehringer Ingleheim’s Jardiance (empagliflozin) and Synjardy (empagliflozin and metformin hydrochloride) picked up another indication, becoming the first and only SGLT2 inhibitors approved for children 10 years and older with type 2 diabetes. Previously, there had only been one oral drug for this indication: metformin, which was approved in 2000.

June 20:
Argenx will bring to market the first subcutaneous injectable for generalized myasthenia gravis (gMG), a rare muscle-wasting autoimmune disease. Vyvgart (efgartigimod) was first approved in 2021 as a one-hour intravenous infusion. Vyvgart is an antibody fragment that binds to the neonatal Fc receptor to prevent recycling of immunoglobulin G back into the blood. This includes a reduction in abnormal AChR antibodies, which are present in approximately 85% of gMG patients. AChR antibodies block the acetylcholine receptors from being able to receive signals from the nerve to stimulate a muscular response. Their normalization should ostensibly improve muscular function.
Heather McKenzie is a senior editor at BioSpace, focusing on neuroscience, oncology and gene therapy. You can reach her at heather.mckenzie@biospace.com. Follow her on LinkedIn and Twitter @chicat08.
Most Read Today
 

FDA Decisions 2023: Sandoz, Gilead Sciences and More | BioSpace

Violence In The Healthcare Workplace

The next time you are in a hospital your nurse may be the target of a verbal or physical assault. The most common location is in the emergency department

Violence in the healthcare workplace is a significant issue affecting healthcare services and workers worldwide. It has far-reaching implications for the well-being of healthcare staff and can jeopardize patient care. Let's delve into the information provided to gain insights into the incidence, trends, and causes of violence in the healthcare workplace and explore measures to address this problem. 

Incidence and Trends of Workplace Violence in Emergency Departments (EDs) in the United Kingdom:A study conducted in the United Kingdom from January 2017 to March 2022 examined workplace violence (WPV) incidents in emergency departments (EDs). The research found that there were statistically significant increases in WPV during the COVID-19 pandemic in March and May 2020. 

Additionally, there were rising trends of WPV in specific regions like London and North-West England over the years preceding the pandemic. The study revealed alarming increases in WPV incidents, indicating a concerning trend in the EDs of the United Kingdom, potentially leading to a demoralized workforce and staff shortages [1].Insights on Workplace Violence Incidents in Healthcare in the United States:A survey conducted by Premier in collaboration with the Agency for Healthcare Research and Quality (AHRQ) revealed that 40 percent of healthcare workers in the United States experienced workplace violence incidents in the last two years. 

The survey highlighted that nursing staff faced violence most frequently, with combative patients being responsible for more than half of all reported incidents. The survey also shed light on the profile of perpetrators, indicating that most were men between the ages of 35 and 65. A notable legislation, the Safety from Violence for Healthcare Employees (SAVE) Act of 2023, was introduced to enhance legal protections for healthcare workers against workplace violence [2].Workplace Violence in Healthcare Settings in the United States: According to an Occupational Safety and Health Administration (OSHA) report, three-quarters of all workplace assaults in the US occur in healthcare settings. 

Healthcare workers, especially nurses, are at an increased risk of being victims of workplace violence. Causes of violence in healthcare settings include factors like the opioid epidemic, reduced funding for behavioral healthcare, misinformation about COVID vaccinations, and restricted visits during isolation. New prevention standards have been mandated to address workplace violence in healthcare settings, emphasizing staff training, de-escalation techniques, and reporting processes [3].In conclusion, violence in the healthcare workplace is a serious concern affecting healthcare workers globally. It poses risks to staff well-being, patient care, and overall healthcare provision. Efforts to combat workplace violence include implementing preventative measures, providing staff training in de-escalation techniques, and enhancing legal protections for healthcare workers. Healthcare organizations need to prioritize employee safety and take comprehensive measures to address this issue effectively.

Women responding to the survey reported that incidents of workplace violence were evenly split between emotional or verbal assaults (50 percent of women responding) and physical or sexual abuse (50 percent). Men responding to the survey were more likely to experience physical abuse (62 percent) versus verbal or emotional assaults (38 percent). 

One in four nurses has been abused in the workplace. Overall, the likelihood of healthcare workers being exposed to violence is higher than prison guards or police officers.

Healthcare workers accounted for 73 percent of all nonfatal workplace injuries and illnesses due to violence in 2018.

The most frequent perpetrators are family of the patient.

Wave of mRNA Vaccines Coming - In Your Food

There has been a longstanding routine vaccination of our animals (cattle, pork) against diseases. In the past these were manufactured with classic non-mRNA methods.

Are you ready for the total transformation of our food supply? There are dozens of veterinary vaccines (and human vaccines, for that matter) in production utilizing the new mRNA technology that underpinned the COVID vaccines. This new technology is entering our food supply under the cover of darkness—granted by censorship imposed during the COVID era that power brokers seem intent on keeping in place.  

What’s often not appreciated is how fundamentally different these vaccines are from previous vaccines. They rely on synthetic biology, essentially blurring the line between biology and technology. This blurring is one of the characteristics World Economic Forum founder and chairman, Klaus Schwab, relates to his dystopian concept of the Fourth Industrial Revolution, which includes gene-edited humans or ‘designer beings’.

We debated GMOs for years, why aren’t we debating the latest bioengineering tech: mRNA? Action Alert!

There are major questions about the long-term consequences of using mRNA technology given its novelty, both for food animals and for humans. Yet there isn’t even a semblance of a public debate about how to move forward or the need for transparency of supply chains including foodstuffs derived from animals treated with mRNA vaccines. This needs to change, especially as mRNA vaccines may well become a mainstay in human and veterinary medicine.

The coming use of mRNA vaccines in livestock presents a massive issue pertaining to our right to know what is in our food. The use of mRNA vaccines in humans is of course another massive public health issue that we’ve written about a number of times over the last three years, such as here and here. It was with a similar sense of humility and caution in the face of this new vaccine technology that we issued a joint call with our colleagues at the Alliance for Natural Health International to protect autoimmune patients from compulsory COVID vaccination.Are you ready for the total transformation of our food supply? There are dozens of veterinary vaccines (and human vaccines, for that matter) in production utilizing the new mRNA technology that underpinned the COVID vaccines. This new technology is entering our food supply under the cover of darkness—granted by censorship imposed during the COVID era that power brokers seem intent on keeping in place.  

The field of mRNA vaccines is exploding. Vaccines based on this novel technology are being explored for cancer treatment, the flu, HIV, hepatitis C, malaria, tuberculosis, and dozens of other diseases. They are also viewed as a boon to the livestock industry by proponents hailing it as a “revolutionary technology.” Researchers are working on mRNA vaccines against porcine reproductive and respiratory syndrome, African swine fever, avian influenza, and other food-animal diseases. Note, however, that there are currently no mRNA vaccines licensed for use in livestock…yet. Additionally, a recent Chinese study broke new ground in demonstrating that mice could be vaccinated against COVID through ingesting milk loaded with mRNA.

To be clear: there are important differences between the mRNA technology used in COVID vaccines and RNA vaccines that have been used in veterinary medicine for some time. In fact, there appears to be little awareness among the public over how much of a departure these new COVID vaccines are from traditional vaccines, this being a direct result of draconian censorship justified by authorities and cop-opted media during the COVID crisis of 2020 to 2022. mRNA vaccines deliver synthetically-produced genetic instructions via a lipid nanoparticle into cells; these instructions then force the vaccinee’s cells to produce whatever protein has been encoded in the instructions. In the case of the COVID vaccines, this is modified and patented version of the spike protein in selected variants of the circulating SARS-CoV-2 virus. It isn’t widely recognized that the spike protein produced following vaccination is different to the spike on the wild virus.

Now that we are poised at this interface of applying the latest bioengineering technology to ourselves and the animals many rely on for food, in full appreciation that we can turn our bodies and those of farm animals into drug factories, we must be humble, not arrogant. Put simply, there are no long-term safety data for any mRNA vaccines whether used on humans or animals, and emerging safety data on COVID vaccines suggests considerably more problems than were anticipated by manufacturers and health authorities at the time of the launch of the mass vaccination program some two and a half years ago.

Any person or authority that claims COVID mRNA vaccines are safe to humans – like the CDC –  is misleading the public. We also have no idea about the long-term, potential effects of eating meat from animals treated with mRNA vaccines coding for different patented proteins once they are approved—especially given the data showing that the lipid nanoparticle coding for the patented spike protein enters the bloodstream and can travel to different areas of the body.

mRNA vaccine technology represents a radical departure from conventional pharmacology that’s ruled the roost in human and veterinary medicine for the last 80 or so years. This is why consumers deserve to know if our food has been treated with these products. We spent years as a society debating the ethics of genetically modified foods, with the public overwhelmingly supporting disclosure of foods with genetic modifications. This culminated in the unfortunate passage of a sham labeling bill that allows food companies to obscure the contents of their products—though legal challenges could improve this situation. But the point is, there was a national debate about this issue.

It is a sign of the times that reasonable questions about the risks and benefits of novel mRNA vaccine platforms are dismissed so readily as anti-vaxxer “misinformation.” If the public can overwhelmingly agree that we need transparency about the contents of our food, the same logic must apply here: we deserve to know if our food has been treated with mRNA technology—whether to immunize the animal against a disease, or in a more Orwellian twist, as a means to deliver a vaccination to those who ingest the food, a possibility raised by the Chinese study referenced above.

As with the GMO labeling issue, states are leading the charge on this. Missouri, Tennessee, and Arizona have bills that require disclosure on food products that have been treated with mRNA vaccines or gene therapy products—though none of these bills appear to be moving forward.

This comes down to the basic issue of transparency, traceability and truth in labeling that allows consumers to make informed decisions about the foods they buy. Given the unknowns with the long-term health effects of the new mRNA vaccination platforms, it is critical that consumers are afforded the opportunity to choose whether they want to ingest foods treated with these vaccines or not.

Are you ready for the total transformation of our food supply? There are dozens of veterinary vaccines (and human vaccines, for that matter) in production utilizing the new mRNA technology that underpinned the COVID vaccines. This new technology is entering our food supply under the cover of darkness—granted by censorship imposed during the COVID era that power brokers seem intent on keeping in place.  

As with the GMO labeling issue, states are leading the charge on this. Missouri, Tennessee, and Arizona have bills that require disclosure on food products that have been treated with mRNA vaccines or gene therapy products—though none of these bills appear to be moving forward.

Action Alert! Write to Congress in support of transparency in labeling on meat products in the event they are treated with mRNA vaccines. Please send your message immediately.

Wave of mRNA Vaccines Coming - Alliance for Natural Health USA - Protecting Natural Health